Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.
from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n
https://ift.tt/eA8V8J
Tuesday, February 26, 2019
Home »
» Crispr Infuses First Human in Landmark Gene-Editing Study
0 comments:
Post a Comment